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What is already known about the topic?
•• Cancer patients in lower socioeconomic groups are significantly less likely to die at home and experience more barriers to 
access to palliative care.
•• Intensity of home care including palliative care is associated with a home death.
•• It is not clear whether and how use of specialist palliative care may modify the effect of socioeconomic status (SES) on place 
of death in cancer patients.
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Abstract
Background: Cancer patients in lower socioeconomic groups are significantly less likely to die at home and experience more 
barriers to access to palliative care. It is unclear whether receiving palliative care may mediate the effect of socioeconomic status on 
place of death.
Aim: This review examines whether and how use of specialist palliative care may modify the effect of socioeconomic status on place 
of death.
Design: A systematic review was conducted. Eligible papers were selected and the quality appraised by two independent reviewers. 
Data were synthesised using a narrative approach.
Data sources: MEDLINE, Embase, CINAHL, PsycINFO and Web of Knowledge were searched (1997–2013). Bibliographies were 
scanned and experts contacted. Papers were included if they reported the effect of both socioeconomic status and use of specialist 
palliative care on place of death for adult cancer patients.
Results: Nine studies were included. All study subjects had received specialist palliative care. With regard to place of death, 
socioeconomic status was found to have (1) no effect in seven studies and (2) an effect in one study. Furthermore, one study found 
that the effect of socioeconomic status on place of death was only significant when patients received standard specialist palliative 
care. When patients received more intense care adapted to their needs, the effect of socioeconomic status on place of death was no 
longer seen.
Conclusion: There is some evidence to suggest that use of specialist palliative care may modify the effect of socioeconomic status 
on place of death.
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What this paper adds?
•• There is some evidence to suggest that use of specialist palliative care may modify the effect of SES on place of death, thus 
contributing to the reduction of inequalities in achieving preferred home death.
•• There is a need for further observational research that fully utilises the existing service patterns and compares the effect 
of SES on place of death between users and non-users of specialist palliative care.
•• The common methodological challenges arise from the complexities in providing palliative care to diverse populations. 
These should be addressed in future research.
Implications for practice, theory or policy
•• Palliative and supportive care services potentially can help cancer patients to die at their preferred place especially if they 
adapt level of care to patients’ unique needs.
Introduction
Despite considerable differences in personal, family and 
cultural meanings associated with dying at home, the 
overwhelming majority (approximately two-thirds) of 
cancer patients identify their own home as the preferred 
place of death;1 and this trend has been found across all 
socioeconomic groups.2–4 However, the majority of 
deaths from all diseases/conditions in most Western 
countries occur in a hospital.1 In the United Kingdom, 
although the proportion of people with cancer dying at 
home has been increasing since 2004, hospital remains 
the most common place of death, and a great discrepancy 
still exists between the preferred and actual place of death 
for cancer patients.5,6
Furthermore, the ability to die at home is unequally dis-
tributed among cancer patients. Research evidence repeat-
edly demonstrates that cancer patients with higher 
socioeconomic status (SES) (e.g. better education, better 
occupation, higher income, living in more affluent or less 
deprived areas) are more likely than patients with lower 
SES to die at home rather than in an institution,1,6–9 and 
this pattern exists in countries with and without universal 
health care programmes.10
According to Grande et al.,7 differences in place of 
death based on SES may be associated with differences 
in access to palliative care services by different socio-
economic groups. They suggested that cancer patients 
in higher socioeconomic groups were more likely to die 
at home possibly because they were more able to access 
services which improved their chances of dying at 
home. In contrast, lower socioeconomic groups experi-
ence many barriers to access although their health care 
needs are greater than those of the general health care 
population.10 Lewis et al.10 identified barriers to access 
in four dimensions: availability, affordability, accepta-
bility and geographical accessibility. For instance, bar-
riers to access may arise from limited availability of 
services in deprived/poor areas (availability); inequi- 
table distribution of services – services far away from 
and thus hard to reach by those with greatest need 
(geographical accessibility); limits of informal care 
arrangements, stigma and mistrust, and communication 
and health literacy issues in lower socioeconomic 
groups (acceptability); and financial burdens for the 
poor accessing services (affordability). As such, lower 
socioeconomic groups are more likely to rely on acute 
care services during illness progression and signifi-
cantly less likely to die at home, both in countries with 
or without universal health care programmes.10,11
However, it is not clear whether or not SES has the 
same effect on place of death when cancer patients receive 
specialist palliative care (see Box 1), having overcome the 
barriers to access; or how the effect of SES on place of 
death differs between those who receive specialist pallia-
tive care and those who do not. This systematic review of 
the worldwide literature therefore aims to examine 
whether or not and how use of specialist palliative care 
may modify the effect of adult cancer patients’ SES on 
place of death.
Methods
Two reviews (Q1 and Q2) were undertaken simultane-
ously, guided by the same protocol due to the overlap 
between their research questions. Q1 (this review) exam-
ines how use of specialist palliative care may modify the 
effect of adult cancer patients’ SES on place of death. Q2 
examines how use of specialist palliative care may modify 
the effect of patients’ age, gender and ethnicity on place of 
death. Search was conducted separately for Q1 and Q2. 
However, search results were pooled together for a com-
bined study selection (see Figure 1) because of overlap-
ping data (i.e. some papers reported socio-demographic 
data which included SES, age, gender and ethnicity). The 
combined study selection helped to reduce the chance of 
missing eligible papers for both reviews. Once eligible 
papers were identified for each review, data extraction, 
quality appraisal and data synthesis were conducted sepa-
rately. Q1 has been completed while Q2 is ongoing. This 
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paper reports on Q1 in adherence to the Preferred Reporting 
Items for Systematic Reviews and Meta-Analyses 
(PRISMA) Statement (http://www.prisma-statement.org/
statement.htm), where applicable.
Information sources and searches
MEDLINE, Embase, CINAHL, PsycINFO and Web of 
Knowledge were searched (January 1997–December 
2013). The search terms (MeSH headings and keywords) 
are summarised in Table 1 and the search strategy for 
MEDLINE and Embase is presented as an example in 
Appendix 1. Experts in the field were contacted to iden-
tify additional references; and the grey literature was 
searched using Caresearch (http://www.caresearch.com.
au/Caresearch/Default.aspx). The reference lists of 
relevant reviews8–10,12 and the included studies13–21 were 
scanned to ensure comprehensiveness of the search. The 
review was limited to English language papers.
Study selection (combined for Q1 and Q2)
Two reviewers (D.J.N. and H.C.) screened all titles and 
abstracts independently. Full-text papers were retrieved 
for those eligible or indeterminable from titles and 
abstracts. Two reviewers (D.J.N. and H.C.) independently 
assessed the full text of all potentially relevant papers. 
Disagreement at each stage was resolved by consensus and 
with recourse to a third reviewer (M.J.) and a fourth (U.M.) 
if necessary.
Eligibility criteria
Papers were included if they reported original, empirical 
data showing the effect of both SES (e.g. income, educa-
tion, occupation) and use of specialist palliative care 
(including hospice care, home care, inpatient or outpatient 
care) on place of death for adult cancer patients 
(⩾18 years). Papers were excluded if the diagnosis was 
unknown or if the paper reported only non-malignant dis-
ease; if the study focussed exclusively on children and on 
preferences or attitudes about place of death rather than 
actual place of death.
Data extraction
A data extraction form was designed and piloted using 
three papers and adjustments made following consensus 
among the research team. Data were independently 
extracted by two reviewers (D.J.N. and H.C.) for 10% of 
the papers using the post-pilot form (see Appendix 2). As 
there was good agreement, the remaining data extraction 
was completed by D.J.N. Information was extracted from 
each included study on design and methods, patient charac-
teristics, measure of SES, type of specialist palliative care, 
place of death outcome, statistical results demonstrating the 
relationships between SES, specialist palliative care, place 
of death and so on. Unreported data or clarifications were 
requested from first authors.
Box 1. 
Palliative care is an approach that improves the quality of life of patients and their families facing the problems associated 
with life-threatening illness, through the prevention and relief of suffering by means of early identification and impeccable 
assessment and treatment of pain and other problems, physical, psychosocial and spiritual.
Source: World Health Organisation 2003
Specialist Palliative Care is the active, total care of patients with progressive, advanced disease and their families. Care is 
provided by a multi-professional team who have undergone recognised specialist palliative care training. The aim of the  
care is to provide physical, psychological, social and spiritual support …
Source: Tebbit, National Council for Palliative Care, 1999
7,196 records idenfied 
through database searching
Addional records idenfied:
14 from references of SRs and included studies 
23 from Grey Literature search and the experts
299 duplicates removed
6,934 records screened 
by 2 independent 
reviewers
6661 records 
excluded
273 full-text papers assessed 
for eligibility by 2 independent 
reviewers
237 full-text papers 
excluded, with 
reasons
9 papers included in 
narrave synthesis for Q1
(This review) 
Papers included for 
Q2
(n = 34)
36 papers included for 
Q1 and Q2
Figure 1. PRISMA flow chart for Q1 and Q2.
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Quality assessment
Quality assessment was conducted independently by two 
reviewers (D.J.N. and H.C.), using the Item Bank for 
Assessing Risk of Bias and Confounding for Observational 
Studies of Interventions or Exposures.22 Disagreement was 
resolved by team consensus. Main methodological compo-
nents assessed include inclusion/exclusion criteria, strat-
egy for recruiting participants, selection of the comparison 
group, variations in intervention/exposures, validity and 
reliability of measures, length of follow-up, attrition and 
control for confounding.
Narrative synthesis
All the included studies are non-randomised, observational 
studies, and there was considerable heterogeneity in meth-
ods, participants and outcomes. Under such circumstances, 
meta-analysis is not sensible and possible, and therefore, a 
narrative approach to synthesis is necessary and appropri-
ate.23,24 Guidance on the Conduct of Narrative Synthesis in 
Systematic Reviews23 was followed, particularly with 
regard to tabulating results; exploring relationships between 
characteristics of individual studies and their reported find-
ings, and between the findings of different studies; and 
overall assessment of the robustness of the evidence.
Results
Altogether, 7196 records were identified through database 
searching for both reviews (Q1 and Q2). Additional 37 
records were identified through reference lists, grey litera-
ture search and the experts. After adjusting for duplicates, 
6934 records remained. Of these, 273 full-text papers were 
retrieved and assessed in detail for inclusion for Q1 and 
Q2 (Figure 1). For this review (Q1), nine papers were 
included which reported nine different empirical studies 
(see Table 2).
Characteristics of included studies
Of the nine included studies, one was conducted in Spain,13 
two in United States,14,15 three in Japan,16–18 two in 
Canada19,20 and one in New Zealand.21 These studies rep-
resent a total of 64,598 patients who received specialist 
palliative care, ranging from 7319 to 61,06314 patients in an 
individual study. The majority of the patients had cancer, 
were White and were aged 65 years and over (see Table 2).
With the exception of one study,14 all aimed to identify 
factors that are associated with place of death for patients 
who had received specialist palliative care. Only one 
study14 specifically examined the relationship between 
income and intensity of specialist palliative care provision 
as a predictor of place of death for patients who received 
home-based specialist palliative care.
All studies are observational, comprising four prospec-
tive cohort studies,13,15,19,20 two retrospective cohort stud-
ies14,21 and three cross-sectional surveys.16–18 Two studies 
collected data by extracting them from administrative or 
clinical database/record;14,21 four studies used a self-devel-
oped questionnaire, which was completed by patients, car-
ers and/or health care professionals with or without 
researcher’s assistance;16–19 and two studies did not 
describe how data were collected.13,15 Multivariate logistic 
regression was used to control for confounding variables, 
except in one study that used Cox proportional-hazards 
regression.15 The confounding variables taken into account 
differ and vary greatly across studies.
Patients’ SES was measured in a variety of ways: edu-
cation in the Spanish study;13 family/household income in 
the American studies;14,15 financial resources in a Canadian 
study19 and in the Japanese studies;16–18 Carstairs depriva-
tion Score25 in another Canadian study;20 and a Community 
Services Card in the New Zealand study.21
All of the patients in the included studies received spe-
cialist palliative care. In one study,15 patients received 
inpatient palliative care provided by freestanding hospices 
Table 1. Search terms.
Cancer Palliative care SES Place of death
Neoplasm
Malignancy
Tumour
Dying
Terminal
Incurable
 
Terminal care
End-of-life care
Cancer care
Home care
Community care
Nursing care
Hospice care
Day care
Macmillan
Marie Curie
Inpatient care
Outpatient care
Supportive care
Social class
Class
Inequality
Deprivation
Poor
Poverty
Disadvantage
Occupation
Education
Income
Location of death
Home death
Hospital death
Hospice death
Nursing home
Aged care home
Residential care home
 
SES: socioeconomic status.
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Table 2. Characteristics of included studies.
Ref. Design and 
methods
Population SES Palliative care Place of death Results
13. Prospective cohort 
study: patients and 
carers followed 
up from patient’s 
admission to death
Patients from single 
service
Logistic regression
Spain
380 Patients
Mean age 
66.76 years
60.5% Male
100% Cancer
Level of education:
9.5% No schooling
50.5% Primary
15.3% Secondary
5.3% High/higher
19.5% Unknown
100% Home 64% Home
19% Hospital
16% Hospice
1% Nursing home
Univariate analysis:
after receiving 
SPC, no differences 
found in place of 
death regarding 
patient’s education 
level 
14. Retrospective 
cohort study: 
review of 
administrative and 
clinical database
Patients from 
multiple services in 
multiple regions
Logistic regression
United States
61,063 Patients
77.7% ⩾65 years
48% Male
70.2% White
64.2% Cancer
Family income:
1.8% ⩽US$20,000
11.6% > 
US$20,000–US$30,000
29.3% > 
US$30,000–US$40,000
24.4% > 
US$40,000–US$50,000
32.9% >US$50,000
Home:
54.9% routine care
45.1% continuous 
care
77.4% Home
22.6% Elsewhere
Multivariate 
analysis:
among those who 
did not receive 
continuous 
care, the odds 
of non-home 
death increased 
as median annual 
household income 
decreased.
Among those 
receiving 
continuous care, 
no significant 
difference was 
found in rates of 
non-home death 
across income 
levels. 
15. Prospective cohort 
study: patients 
followed up from 
admission to death 
or end of study 
period
Patients from 
multiple services in 
single region
Cox proportional-
hazards regression
United States
180 Patients
Mean age 
67 years
49.4% Male
79.4% White
100% Cancer
Family income 
(n = 142):
31.7% <US$20,000
39.4% ⩾US$2000 and 
<US$40,000
28.9% >US$40,000
100% Inpatient 23.7% Home
40.8% Hospice
25% Hospital
10.5% Nursing 
home
Bivariate analysis:
the inpatient-
hospice-death 
group and the 
censored group 
were comparable 
on family income
16. Cross-sectional 
survey of home 
hospice care 
agencies
Patients from 
multiple services in 
multiple regions
Logistic regression
Japan
528 Patients
Mean age 
75 years
59.5% Male
100% Cancer
Financial sufficiency:
40.7% yes
59.3% No
100% Home 64.8% Home
35.2% Hospital
Univariate analysis:
after receiving 
SPC, no differences 
found in place of 
death regarding 
patient’s financial 
situation 
17. Cross-sectional 
survey of home 
hospice care 
agencies
Patients from 
multiple services in 
multiple regions
Logistic regression 
for multivariate 
analysis
Japan
428 Patients
Mean age 
75 years
57.8% Male
100% Cancer
Financial sufficiency:
Proportion not 
reported
100% Home 64.8% Home
35.2% Hospital
Univariate analysis:
after receiving 
SPC, no differences 
found in place of 
death regarding 
patient’s financial 
situation 
(Continued)
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or dedicated units located in hospitals. In another study,21 
patients received home palliative care in addition to outpa-
tient and/or inpatient palliative care. In the remaining 
seven studies, patients received home palliative care.
Categorisation of place of death differs in the studies. 
All the studies have home as an outcome of place of death, 
which is compared with ‘hospital, hospice and aged/resi-
dential care home’ in three studies,13,15,21 with ‘other than 
home’ in one study,14 with ‘hospital + hospice’ in one 
study19 and with ‘hospital’ in four studies.16–18,20
Common methodological limitations included sample 
unrepresentative, insufficient controlling for confounding 
factors and imprecise measurement of SES and use of spe-
cialist palliative care, all of which exist in the included 
studies in varying degrees (see ‘Discussion’).
Does use of specialist palliative care modify the 
effect of SES on place of death?
In seven studies (sample size: 73–568 patients), univariate 
or bivariate analysis found no statistically significant dif-
ferences in place of death regarding SES among patients 
who received home care13,16–20 or inpatient care15 (see 
Table 2). Two studies14,21 did find statistically significant 
differences in place of death regarding SES.
Taylor et al.21 found SES to be a predictive factor of 
place of death for patients receiving specialist palliative 
care. In this study, retrospective administrative data were 
obtained from a hospice in New Zealand. Although 1268 
patients were included, only 890 patients had information 
recorded about whether or not they had a Community 
Ref. Design and 
methods
Population SES Palliative care Place of death Results
18. Cross-sectional 
survey of home 
hospice care 
agencies
Patients from 
multiple services in 
multiple regions
Logistic regression
Japan
568 Patients
Mean age 
73 years
59.7% Male
100% Cancer
Financial sufficiency:
47.4% yes
52.6% No
100% Home 54.9% Home
45.1% Hospital
Univariate analysis:
after receiving 
SPC, no differences 
found in place of 
death regarding 
patient’s financial 
situation  
19. Prospective cohort 
study: patients, 
carers and family 
physicians followed 
up from patient’s 
admission to death
Patients from single 
service
Logistic regression
Canada
73 Patients
Mean age 
68 years
48% Male
100% Cancer
Financial resources 
sufficient (n = 67):
77.6% Yes
22.4% No
100% Home 47% home
53% Hospital + 
Hospice
Univariate analysis:
after receiving 
SPC, no differences 
found in place of 
death regarding 
patient’s financial 
situation 
20. Prospective cohort 
study: primary 
carers followed 
up from patient’s 
admission to death
Patients from single 
service
Logistic regression
Canada
110 Patients 
55.5% 
⩾70 years
46.4% Male
100% Cancer
Carstairs Deprivation 
score:
24.8% ⩽ 0.5
25.7% 0.51–0.64
24.8% 0.65–1.07
24.8% ⩾ 1.08
100% Home 66.4% Home
33.6% Hospital
Univariate analysis:
after receiving 
SPC, no differences 
found in place of 
death regarding 
patient’s 
deprivation level 
21. Retrospective 
cohort study: 
review of hospice 
chart
Patients from single 
service
Multinomial logistic 
regression
New Zealand
1268 Patients
72% > 65 years.
48% Male
82% European
82% Cancer
Community Services 
Card:
42% Yes
28% No
30% Missing data
100% Home+ 
other
28% Home
46% hospice
8% hospital
16% care home
Multivariate 
analysis:
relative to those 
people without 
a CSC, people 
with a CSC were 
more likely to die 
at acute hospital 
than at home 
(OR = 2.09, 95% 
CI: 1.096–3.996)  
SES: socioeconomic status; SPC: specialist palliative care; CSC: Community Services Card; OR: odds ratio; CI: confidence interval.
Table 2. (Continued)
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Services Card (CSC). Having a CSC is a crude indicator of 
lower SES. Multivariate analysis of these patients (con-
trolling for age, ethnicity, marital status, gender and medi-
cal condition) showed that relative to those people without 
a CSC, people with a CSC were more likely to die at acute 
hospital than at home (odds ratio (OR) = 2.09, 95% confi-
dence interval (CI): 1.096–3.996). There was no signifi-
cant difference between those with/without a CSC 
regarding likelihood of dying in an aged/residential care 
facility relative to home (OR = 1.50, 95% CI: 0.88–2.565). 
Likewise, there was no evidence for CSC status to differ-
entiate between likelihood of dying in the hospice inpa-
tient unit relative to home (OR = 1.00, 95% CI: 
0.71–1.42).
Barclay et al.’s14 was the largest study, which included 
61,063 patients (64.2% with cancer). It was a retrospective 
administrative dataset obtained from a hospice provider 
that operated 26 hospice programmes in eight states in the 
United States. Altogether, 77.4% of 61,063 patients died at 
home. Two levels of home care (routine versus continu-
ous) were provided to these patients based on their needs; 
54.9% of the patients received routine home care only 
(periodic home visits) and 45.1% received continuous 
home care, that is, a short-term intense period of care that 
included the presence of hospice staff providing care for a 
minimum of 8 h in a 24-h period, with at least half the care 
provided by a nurse. In the multivariate model, the 
income × level of care interaction was significant in pre-
dicting place of death, after controlling for confounding 
factors including sex, age, ethnicity, marital status, disease 
type, payment source, enrolment in a health maintenance 
organisation, relationship of the primary caregiver to the 
enrolee, days in hospice care and hospice programme loca-
tion by region. In the routine-care group, the odds of non-
home death increased as median annual household income 
decreased. Those in the lowest income group compared 
with those in the highest income group had almost twice 
the odds of dying elsewhere rather than home (OR = 1.76, 
95% CI: 1.48–2.09). In comparison, in the continuous-care 
group, no significant difference was found in rates of non-
home death across income levels; and for all income lev-
els, a smaller proportion of those receiving any continuous 
care (vs no continuous care) died elsewhere rather than 
home.
Discussion
Gomes and Higginson8 found strong evidence for the asso-
ciation of SES (i.e. education, social class, income) with 
place of death for patients with cancer. They found that the 
evidence that supported the influence of SES was stronger 
than the evidence that showed no effect, suggesting that 
higher SES increased the odds of home death. They also 
found strong and consistent evidence to suggest that inten-
sity of home care (more home care input and more frequent 
visits) was associated with a home death. However, their 
review did not examine the link between the two associa-
tions, that is, whether or not SES and intensity of home care 
may interact together to impact on place of death in cancer 
patients. This review is particularly interested in whether or 
not and how use of specialist palliative care may modify 
the effect of SES on place of death. The majority of the 
included studies (seven) found that SES had no effect on 
place of death among users of home-based specialist pallia-
tive care13,16–20 or inpatient specialist palliative care.15 Only 
one study found that SES had an effect on place of death 
among users of specialist palliative care (home, outpatient 
and/or inpatient).21 However, the biggest study14 
(n = 61,063) found that the effect of SES on place of death 
was only significant when patients received standard home-
based specialist palliative care. When patients received 
more intense home care that was adapted to their needs, 
SES stopped having an effect on place of death. Moreover, 
intensity of home care adapted to patients’ needs particu-
larly at the end of life increased the chance of home death 
across all socioeconomic groups. Particularly, for patients 
in lower socioeconomic groups, more intense home care 
meant that they had a higher chance of home death despite 
the fact that they had been identified as having increased 
needs. These findings thus suggest that use of specialist 
palliative care may modify the effect of SES on place of 
death and thus help to reduce inequalities in achieving pre-
ferred home death.
Nonetheless, definite conclusions cannot be reached 
because not only is there a paucity of empirical studies 
identified but also considerable heterogeneity exists in 
the study characteristics. Moreover, all the studies had 
some methodological weakness, which may have con-
tributed to underestimates or overestimates of the actual 
effect of SES and use of specialist palliative care on 
place of death.
Selection bias was common. In four studies,13,19–21 
patients were recruited from a single service; even in stud-
ies where patients were recruited from multiple services in 
one region15 or in multiple regions,14,16–18 findings may not 
be generalisable to other populations or geographical 
areas, since palliative care services and health and social 
care environments differ in different areas, regions in the 
same country and between countries.
Another major methodological problem is controlling 
for confounding variables because there is a complicated 
network of factors that affect both use of specialist pallia-
tive care services and place of death.8,26 These factors fall 
into three groups: those related to the illness, the individ-
ual and the care and social environment.8 Both studies,14,21 
in which SES was entered into the multivariate regression 
model as a significant predictor of place of death, lacked 
specific patient, clinician, health system or environmental 
variables that might represent important sources of resid-
ual confounding.27
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One of the key variables of this review – SES – is a 
complex concept that often refers to the position of indi-
viduals, families, households or other aggregates on one or 
more dimensions of stratification.28 These dimensions 
include income, education, prestige, wealth or other 
aspects of standing that members of society deem salient. 
Each of these dimensions is capable of exerting separate 
effects although they are interrelated. Bollen et al.28 found 
that although SES was widely referred to in health and 
health care research, there is a lack of consensus with 
respect to its conceptual meaning and measurement. The 
same problem persists in this review. SES was measured 
differently across studies – by different singular or aggre-
gated dimensions (i.e. education, household income, 
financial resources and deprivation). As such, outcomes of 
SES are not comparable across studies. Also, data availa-
bility clearly influenced the ways in which SES was meas-
ured, leading to imprecise and ambiguous measurement 
(e.g. Community Services Card).
With regard to use of specialist palliative care, practice 
variations prevail in and across the studies. First, the com-
position of multi-disciplinary team differed across the 
studies that reported such information: in the Spanish 
study, it consisted of doctor, advanced nurse, assistant 
nurse and administrative clerk;13 in an American study, it 
consisted of doctor, nurse, home health aide, chaplain and 
social worker;14 in a Canadian study, it consisted of nurse, 
social worker, occupational therapist, physical therapist, 
respiratory therapist and volunteers;19 in the Japanese 
studies, it consisted of home care nurse and patient’s fam-
ily doctor and/or hospital doctor;16–18 in the New Zealand 
study, it consisted of doctor, nurse, chaplain, social worker, 
counsellor and music, massage, occupational and physio-
therapists.21 Second, the frequency and intensity of peri-
odic home care varied. In some studies, level of care was 
adapted to the needs of patients and families; for example, 
in an American study, a short-term intense period of care 
was provided to patients at the end of life, which included 
a minimum of 8-h care in a 24-h period, with at least half 
the care provided by a nurse;14 in a Canadian study, 4–5 h/
day or more of services can be provided to patients with 
advanced disease and 24-h nursing and personal care may 
be provided for a short period at end of life.19 Third, pallia-
tive care services were provided free of charge in Spain, 
Canada and New Zealand, whereas in United States and 
Japan, they were mainly covered by medical insurance. 
Such varying practices were not sufficiently reflected in 
the measures for the use of specialist palliative care.
In all, this review found some evidence to suggest that 
use of specialist palliative care may modify the effect of 
SES on place of death and is the first to synthesise such 
evidence. The general implication of the findings for prac-
tice is that palliative and supportive care services poten-
tially can help cancer patients in all socioeconomic groups 
to die at their preferred place, especially if they adapt level 
of care to patients’ unique needs. The review also identi-
fied a need for more rigorous empirical evidence in this 
area and highlighted the methodological issues to be dealt 
with in future research. Due to the challenges in the use of 
randomised controlled trial designs, observational data 
sources and study designs will continue to be strong con-
tributors to building the evidence base for palliative care 
research and practice.27 As such, future observational 
research needs to consider how to (1) reduce selection 
bias; (2) collect data about a myriad of confounding fac-
tors, particularly those related to the individual and the 
care and social environment; (3) better define and measure 
SES; and (4) more precisely measure use of specialist pal-
liative care to reflect practice variations and complexities 
in service provision. To further ascertain that use of spe-
cialist palliative care can modify the effect of SES on place 
of death, a better design would be to utilise existing pat-
terns of practice and prospectively or retrospectively com-
pare the effect of SES on place of death between users and 
non-users of specialist palliative care.
Conclusion
There is some evidence to suggest that use of specialist 
palliative care may modify the effect of SES on place of 
death, thus contributing to reducing inequalities in achiev-
ing the preferred home death. This also means that pallia-
tive and supportive care services potentially can help 
cancer patients die at their preferred place by adapting 
level of care to their unique needs. However, more rigor-
ous empirical studies are needed to further confirm this 
finding. Future observational studies need to fully utilise 
the existing service patterns and compare the effect of SES 
on place of death between users and non-users and also 
pay more attention to selection bias, controlling for con-
founding factors and measurement of SES and use of spe-
cialist palliative care.
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Appendix 1
Search strategy–MEDLINE and Embase
(MEDLINE and Embase Jan 1997–Dec 2013)
1. exp Neoplasm/
2. Neoplasm*.mp.
3. cancer*.mp. [mp=ti, ab, sh, hw, tn, ot, dm, mf, dv, kw, nm, kf, ps, rs, ui]
4. or/1-3
5. exp Social Class/
6. Social Class*.mp.
7. Socio-econom*.mp.
8. socioeconom*.mp.
9. Inequalit*.mp. [mp=ti, ab, sh, hw, tn, ot, dm, mf, dv, kw, nm, kf, ps, rs, ui]
10. exp Poverty/
11. poverty.mp.
12. or/5-11
13. exp Hospices/
14. Hospic*.mp.
15. exp Terminal care/
16. Terminal care.mp.
17. exp Palliative care/
18. Palliat$.mp.
19. exp End-of-life/
20. place of death.adj
21. location.mp. [mp=ti, ab, sh, hw, tn, ot, dm, mf, dv, kw, nm, kf, ps, rs, ui]
22. Hospitals/
23. Hospitals.mp.
24. Health Services Access*.mp. [mp=ti, ab, sh, hw, tn, ot, dm, mf, dv, kw, nm, kf, ps, rs, ui]
25. exp Inpatient/
26. Inpatient.mp.
27. exp Outpatient/
28. Outpatient.mp.
29. or/13-28
30. 4 and 12 and 29
31. limit 30 to English language
32. limit 31 to yr=‘1997–Current’
33. limit 32 to humans
34. remove duplicates from 33
Study ID:
Author: Year:
Article title:
Article type: Paper
Conference abstract
Other:
Reviewer: Date:
Appendix 2
Data extraction form
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2. PARTICIPANT DETAILS.
1.1 Research aim(s)/question(s):
Population:
Exposure:
Outcome:
1.2 Study design:
 Cross-sectional survey
 Prospective cohort
 Retrospective cohort
 Other:
1.3 Setting of study:
 Country:
 Urban/rural/mixed:
 Other:
1.4 Study period (in months):
 Duration:
 Follow-up (if prospective):
1.5 Sample selection Method:
 Random
 Convenience
 Consecutive
 Other:
1.6 Data source/method of measurement:
 Record review
 Questionnaire
 Other:
1.7 Method of data analysis/statistical tests:
2.1 Study Inclusion/exclusion criteria:
Inclusion: Exclusion:
1. NATURE OF STUDY.
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N (%) N (%)
Total Total  
Age: Disease type:
 cancer  
 Non-cancer  
 Access to Palliative Care:
 Inpatient  
 Outpatient  
Gender: Home care  
Male Community care  
Female Day care  
Other  
Ethnicity:  
  
 Place of death:
 Home/care home  
 Hospital  
SES: Hospice  
  
  
  
2.2 Participant characteristics:
3. MAIN FINDINGS.
3.1 Numerical results re association between study variables:
3.2 Summary of narrative results re association between study variables:
3.3 Authors conclusions:
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